Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis

Experimental Eye Research

Volumn 77, Issue 2, 2003, Pages 227-237

  Yang, Yan Ning ^a,b   Bauer, Dirk ^a,b   Wasmuth, Susanne ^a,b   Steuhl, Klaus Peter ^b   Heiligenhaus, Arnd ^a,b  

^a ST FRANZISKUS HOSPITAL   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cornea; Herpes simplex virus; Keratitis; Matrix metalloproteinases; Tissue inhibitor of metalloproteinases; Ulcer

Indexed keywords

GELATINASE A; GELATINASE B; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA CELL; CORNEA ULCER; ENZYME ACTIVITY; EXPERIMENTAL TEST; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; IMMUNOCYTOCHEMISTRY; MOUSE; NECROSIS; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 0038504672     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4835(03)00112-X     Document Type: Article

References (41)

1. Bauer D., Mrzyk S., Van Rooijen N., Steuhl K.P., Heiligenhaus A. Macrophage-depletion influences the course of murine HSV-1 keratitis. Curr. Eye Res. 20:2000;45-53.
2. Bauer D., Mrzyk S., Van Rooijen N., Steuhl K.P., Heiligenhaus A. Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages. Exp. Eye Res. 72:2001;261-269.
3. Brew K., Dinakarpandian D., Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta. 1477:2000;267-283.
4. Das S.K., Yano S., Wang J., Edwards D.R., Nagase H., Dey S.K. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period. Dev. Genet. 21:1997;44-54.
5. De Clerck Y.A., Darville M.I., Eeckhout Y., Rousseau G.G. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinase-2 (TIMP-2). Gene. 139:1994;185-191.
6. Fini M.E., Cook J.R., Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch. Dermatol. Res. 290:1998;S12-S23.
7. Fini M.E., Girard M.T. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest. Ophthalmol. Vis. Sci. 31:1990;1779-1788.
8. Fini M.E., Parks W.C., Rinehart W.B., Girard M.T., Matsubara M., Cook J.R., West-Mays J.A., Sadow P.M., Burgenson R.E., Jeffrey J.J., Raizman M.B., Krueger R.R., Zieske J.D. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am. J. Pathol. 149:1996;1287-1302.
9. Fini M.E., Yue B.Y., Sugar J. Collagenolytic/gelatinolytic metalloproteinases in normal and keratoconus corneas. Curr. Eye Res. 11:1992;849-862.
10. Garrana R.M.R., Zieske J.D., Assouline M., Gipson I.K. Matrix metalloproteinases in epithelia from human recurrent corneal erosion. Invest. Ophthalmol. Vis. Sci. 40:1999;1266-1270.
11. Gipson T.S., Nicolas M.B., Shanley T.P., Crouch L.D., Bleavins M.R., Younkin E.M., Sarma V., Gibbs D.F., Tefera W., McConnell P.C., Mueller W.T., Johnson K.J., Ward P.A. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury. J. Immunol. 162:1999;3653-3662.
12. Girard M.T., Matsubara M., Kublin C., Tessier M.J., Cintron C., Fini M.E. Stromal fibroblasts synthesize collagenase and stromelysin during long-term tissue remoddeling. J. Cell. Sci. 104:1993;1001-1011.
13. Gomez D.E., Alonso D.F., Yoshiji H., Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological function. Eur. J. Cell. Biol. 74:1997;111-122.
14. Heiligenhaus A., Bauer D., Meller D., Steuhl K.P., Tseng S.C. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Invest. Ophthalmol. Vis. Sci. 42:2001;1969-1974.
15. Heiligenhaus A., Bauer D., Zheng M., Mrzyk S., Steuhl K.P. CD4+ T-cell type 1 and type 2 cytokines in the HSV-1 infected cornea. Graefe's Arch. Clin. Exp. Ophthalmol. 237:1999;399-406.
16. Heiligenhaus A., Berra A., Foster C.S. CD4+ Vβ8+ T cells mediate herpes stromal keratitis. Curr. Eye Res. 13:1994;711-716.
17. Heiligenhaus A., Foster C.S. Histological and immunopathological analysis of T-cells mediating murine HSV-1 keratitis. Graefe's Arch. Clin. Exp. Ophthalmol. 232:1994;628-634.
18. Hendricks R.L., Tumpey T.M., Finnegan A. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J. Immunol. 149:1992;3023-3028.
19. Kernacki K.A., Barrett R., Hazlett L.D. Evidence for TIMP-1 against P. aeruginosa-induced corneal ulceration and perforation. Invest. Ophthalmol. Vis. Sci. 40:1999;3168-3176.
20. Kernacki K., Fridman R., Hazlett L.D., Lande M.A., Berk R.S. In vivo characterization of host and bacterial protease expression during Pseudomonas aeroginosa corneal infections in naïve and immunized mice. Curr. Eye Res. 16:1997;289-297.
21. Kossakowska A.E., Edwards D.R., Lee S.S., Urbanski L.S., Stabbler A.L., Zhang C.L., Philips B.W., Zhang Y.K., Urbanski S.J. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am. J. Pathol. 153:1998;1895-1902.
22. Kvanta A., Sarman S., Fagerholm P., Seregard S., Steen B. Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization. Exp. Eye Res. 70:2000;419-428.
23. Liesegang T.J., Melton J., Daly P.J., Ilstrup D.M. Epidemiology of ocular herpes simplex: Incidence in Rochester Minn, 1950 through 1982. Arch. Ophthalmol. 107:1989;1155-1159.
24. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remodelling. Trend Genet. 6:1990;121-125.
25. Matsubara M., Girard M.T., Kublin C.L., Cintron C., Fini M.E. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Dev. Biol. 147:1991;425-439.
26. Nagase H. Hooper N.M. Zinc Metalloproteases in Health and Disease. 1996;153-204 Taylor and Francis, London.
27. Niemaltowski M.G., Rouse B.T. Predominance of Th-1 cells in ocular tissue during herpetic stromal keratitis. J. Immunol. 149:1992;3035-3039.
28. O'Brien T.P., Li Q.J., Sauerburger F., Reviglio V.E., Rana T., Ashraf M.F. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use. Ophthalmology. 108:2001;656-659.
29. Parks W.C. Matrix metalloproteinases in repair. Wound Rep. Reg. 7:1999;423-432.
30. Pfister R.R., Haddox J.L., Sommers C.L. Injection of chemoattractants into normal cornea: a model of inflammation after alkali injury. Invest. Ophthalmol. Vis. Sci. 39:1998;1744-1750.
31. Ries C., Petrides P.E. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Bio. Chem. Hoppe-Seyler. 376:1995;345-355.
32. Saika S., Kawashima Y., Okada Y., Tanaka S.I., Yamanaka O., Ohnishi Y. Recombinant TIMP-1 and -2 enhance the proliferation of rabbit corneal epithelial cells in vitro and the spreading of rabbit corneal epithelium in situ. Curr. Eye Res. 17:1998;47-52.
33. Schultz G.S., Strelow S., Stern G.A., Chegini N., Grant M.B., Garlardy R.E., Grobelny D., Rowsey J.J., Stonecipher K., Parmley V., Khaw P.T. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases. Invest. Ophthalmol. Vis. Sci. 33:1992;3325-3331.
34. Smith V.A., Hoh H.B., Easty D.L. Role of ocular matrix metalloproteinases in peripheral ulcerative keratitis. Br. J. Ophthalmol. 83:1999;1376-1383.
35. Streilein J.W., Dana R., Ksander B.R. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol. Today. 18:1997;443-449.
36. Thomas J., Gangappa S., Kanangat S., Rouse B.T. On the essential involvement of neutrophils in the immunopathologic disease, Herpetic stromal keratitis. J. Immunol. 158:1997;1383-1391.
37. Thomas J., Rouse B.T. Immunopathogenesis of herpetic ocular disease. Immun. Res. 16:1997;375-386.
38. Treibel S., Blaser J., Gote T. Evidence for the tissue of inhibitor of metalloproteinase-1 in human polymorphonuclear leukocytes. Eur. J. Biochem. 231:1995;714-719.
39. Tumpey T.M., Chen S.H., Oakes J.E., Lausch R.N. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70:1996;898-904.
40. Will H., Atkinson S.J., Butler G.S., Smith B., Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation Regulation by TIMP-2 and TIMP-3. J. Biol. Chem. 271:1996;17119-17123.
41. Woessner J.F. Jr. Parks W.C., Mecham R.P. Matrix Metalloproteinases. 1998;1-4 San Diego, Academic Press.